89bio, Inc

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell 89bio, Inc and other ETFs, options, and stocks.

About ETNB

89bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Its product pipeline includes pegozafermin, FGF21, NASH, and SHTG.

CEO

Rohan Palekar

CEORohan Palekar

Employees

Employees93

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

2018

Founded2018

Employees

Employees93

ETNB Key Statistics

Market cap

1.48B

Market cap1.48B

Price-Earnings ratio

-3.01

Price-Earnings ratio-3.01

Dividend yield

—

Dividend yield—

Average volume

1.94M

Average volume1.94M

High today

$10.23

High today$10.23

Low today

$9.96

Low today$9.96

Open price

$10.22

Open price$10.22

Volume

691.36K

Volume691.36K

52 Week high

$11.84

52 Week high$11.84

52 Week low

$4.16

52 Week low$4.16

Analyst ratings

80%

of 10 ratings

Buy

80%

Hold

20%

Sell

People also own

Based on the portfolios of people who own ETNB. This list is generated using Robinhood data, and it’s not a recommendation.